CHINA UNIVERSAL ASSET MANAGEMENT CO., LTD. Halozyme Therapeutics, Inc. Transaction History

CHINA UNIVERSAL ASSET MANAGEMENT CO., LTD. portfolio value:

$986,000
portfolio value

Halozyme Therapeutics, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Increase 0.00% 24.93K shares 986K $39.54 24.93K